IMDX Insight Molecular Diagnostics Inc. - Common Stock
$4.38
가격 · 8월 25, 2026
기준 재무 정보 8월 10, 2026
52주 범위
$2–$9
33% of range
애널리스트 평점
BUY
10 analysts
목표 주가
$8
+89% upside
P/E (TTM)
-2.7
ROE
330.8%
순이익률
-1238.5%
IMDX 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$4.38
시가총액
$126M
P/E (TTM)
-2.7
EPS (TTM)
$-1.65
매출 (TTM)
$4M
배당 수익률
—
ROE
330.8%
부채/자본
—
52주 범위
$2 – $9
IMDX 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$4M
2020-12-31
→
2025-12-31
EPS
$-1.65
2022-12-31
→
2025-12-31
잉여현금흐름
$-25M
2016-12-31
→
2025-12-31
마진
-1238.5%
2023-12-31
→
2025-12-31
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
IMDX
동종업계 중앙값
P/E (TTM)
-2.7
—
P/S (TTM)
31.0
28.5
P/B
-4.0
2.2
Price / FCF (주가 / FCF)
-4.9
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
IMDX
동종업계 중앙값
Gross Margin (매출 총이익률)
56.7%
51.3%
Operating Margin (영업이익률)
-1260.8%
—
Net Profit Margin (순이익률)
-1238.5%
-1348.1%
ROA
-165.1%
-100.0%
ROE
330.8%
-154.7%
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
IMDX
동종업계 중앙값
Current Ratio (유동비율)
1.3
2.9
Quick Ratio (당좌 비율)
1.1
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
IMDX
동종업계 중앙값
Revenue YoY (매출 YoY)
115.6%
—
Revenue CAGR 3Y (매출 CAGR 3년)
61.8%
—
Revenue CAGR 5Y (매출 CAGR 5년)
27.2%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
IMDX
동종업계 중앙값
IMDX 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
10 명의 애널리스트
- 적극 매수 2 20.0%
- 매수 5 50.0%
- 보유 3 30.0%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
4 명의 애널리스트 · 2026-08-25
중앙값
$8.50
지금
$4.38
저가
$4.00
고가
$12.00
중앙값 목표
$8.50
+94.2%
평균 목표
$8.25
+88.5%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.29%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.23 | $-0.25 | 0.02% |
| 2026년 3월 31일 | $-0.12 | $-0.27 | 0.15% |
| 2025년 12월 31일 | $-0.72 | $-0.24 | -0.48% |
| 2025년 9월 30일 | $-0.34 | $-0.21 | -0.13% |
| 2025년 6월 30일 | $-0.30 | $-0.23 | -0.07% |
| 2025년 3월 31일 | $-0.26 | $-0.24 | -0.02% |
| 2024년 12월 31일 | $-1.93 | $-0.44 | -1.5% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| IMDX | $215M | -4.5 | 115.6% | -1238.5% | 330.8% | 56.7% |
| UNCY | $128M | -3.5 | -29.0% | — | -113.9% | — |
| CNTB | $159M | -2.8 | -99.8% | -86687.5% | -97.9% | — |
| EQ | $95M | -4.0 | 13.9% | — | -133.1% | — |
| SPRB | $120M | -1.7 | -51.3% | — | -139.9% | — |
| CYPH | $97M | 16.6 | — | — | 6.1% | — |
| HURA | — | -1.2 | — | — | — | — |
| CBUS | — | -0.6 | -14.6% | -3492.3% | -223.0% | — |
| VTVT | — | — | — | — | -70.4% | — |
| ANIX | $136M | -12.1 | 0.00% | — | -62.2% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Cost of Revenue | $2M | $1M | $1M | $880.0K | $697.0K | $2M | · | · | · | · | · | |
| Gross Profit | $2M | $740.0K | $413.0K | $-18.0K | $1M | $-639.0K | · | · | · | · | · | |
| R&D Expense | $16M | $10M | $9M | $7M | $5M | $10M | $7M | $7M | $7M | $6M | $5M | |
| SG&A Expense | $11M | $10M | $11M | $22M | $22M | $17M | $13M | $7M | $9M | $4M | $4M | |
| Operating Expenses | $53M | $62M | $26M | $18M | $55M | $29M | $22M | $15M | $19M | $11M | $9M | |
| Operating Income | $-51M | $-61M | $-25M | $-18M | $-54M | $-30M | $-22M | $-15M | $-19M | $-11M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $0 | $18.0K | |
| Other Non-op | $1M | $462.0K | $394.0K | $-61.0K | $-37.0K | $27.0K | $-3.0K | $91.0K | $-309.0K | $0 | $2.0K | |
| Pretax Income | · | $-61M | $-25M | $-19M | $-53M | $-31M | $-22M | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | · | $-9M | $-1M | · | · | · | · | · | |
| Net Income | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| EPS (Basic) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | $-0.72 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.65 | $-4.66 | $-3.75 | $-13.25 | · | · | · | · | · | · | · | |
| Shares (Basic) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | 88,920 | · | · | · | · | · | · | |
| Shares (Diluted) | 30,476,000 | 13,071,000 | 7,651,000 | 5,540,000 | · | · | · | · | · | · | · | |
| EBITDA | $-49M | $-59M | $-25M | · | · | · | · | · | · | $-11M | · |
대차대조표 25
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $9M | $9M | $20M | $33M | $7M | $22M | $8M | $8M | $10M | $8M | |
| Receivables | $1M | $2M | $484.0K | $2M | $1M | $203.0K | · | · | · | · | · | |
| Inventory | $446.0K | $410.0K | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $821.0K | $643.0K | $977.0K | $901.0K | $1M | $505.0K | $180.0K | $168.0K | $285.0K | $388.0K | |
| Other Current Assets | · | · | · | · | $85.0K | $295.0K | $36.0K | $78.0K | · | $103.0K | $22.0K | |
| Current Assets | $15M | $12M | $11M | $26M | $39M | $9M | $23M | $9M | $9M | $13M | $11M | |
| PP&E (Net) | $6M | $6M | $5M | $9M | $7M | $4M | $4M | $614.0K | $822.0K | $688.0K | $576.0K | |
| PP&E (Gross) | · | · | · | · | $7M | $2M | $1M | $2M | $1M | $1M | $750.0K | |
| Accum. Depreciation | $7M | $8M | $6M | $4M | $3M | $1M | $343.0K | $948.0K | $657.0K | $319.0K | $174.0K | |
| Goodwill | · | · | · | · | $19M | $9M | · | · | · | · | · | |
| Intangibles | $0 | $15M | $57M | $62M | $62M | $15M | · | · | $746.0K | $988.0K | $1M | |
| Other Non-current Assets | $593.0K | $691.0K | $463.0K | $371.0K | $264.0K | $356.0K | $93.0K | · | · | · | · | |
| Total Assets | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Accounts Payable | $3M | $2M | $953.0K | $1M | $2M | $432.0K | $469.0K | $166.0K | $175.0K | $422.0K | $285.0K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $3M | · | · | $636.0K | $549.0K | $325.0K | |
| Current Liabilities | $12M | $7M | $7M | $12M | $14M | $9M | $4M | $6M | $4M | $4M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | $187.0K | $289.0K | $310.0K | $0 | |
| Total Liabilities | $57M | $47M | $49M | $60M | $94M | $22M | $9M | $6M | $6M | $5M | $2M | |
| Long-term Debt | · | · | · | · | · | · | · | · | $2M | · | · | |
| Common Stock | $369M | $338M | $310M | $295M | $253M | $157M | $125M | $75M | $60M | $46M | $35M | |
| Retained Earnings | $-401M | $-351M | $-290M | $-261M | $-188M | $-124M | $-94M | $-71M | $-55M | $-35M | $-24M | |
| AOCI | $86.0K | $21.0K | $49.0K | $39.0K | $37.0K | · | · | · | $-888.0K | $-654.0K | $-350.0K | |
| Stockholders' Equity | $-31M | $-12M | $20M | $34M | $65M | $33M | $31M | $3M | $4M | $10M | $10M | |
| Liabilities + Equity | $26M | $35M | $75M | $100M | $160M | $55M | $40M | $10M | $10M | $14M | $13M | |
| Shares Outstanding | 28,683,000 | 17,453,000 | 8,261,000 | 5,932,000 | 92,232,000 | 69,117,000 | 57,032,000 | 40,664,000 | 31,452,000 | 28,737,000 | 25,391,000 |
현금 흐름 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $800.0K | $313.0K | · | · | · | · | · | |
| Stock-based Comp | $2M | $2M | $3M | $10M | $7M | $5M | $3M | $1M | $2M | · | · | |
| Deferred Tax | · | · | $0 | $0 | $-9M | $-1M | · | · | · | · | · | |
| Amort. of Intangibles | $7.0K | $88.0K | $88.0K | $4M | $3M | $81.0K | · | $121.0K | $242.0K | $242.0K | $242.0K | |
| Other Non-cash | $24M | $37M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-22M | $-21M | $-23M | $-46M | $-36M | $-26M | $-20M | $-12M | $-13M | $-8M | $-4M | |
| CapEx | $3M | $516.0K | $281.0K | $4M | $2M | $1M | $918.0K | $31.0K | $91.0K | $106.0K | $500.0K | |
| Investing Cash Flow | $-3M | $-512.0K | $-932.0K | $-4M | $-14M | $-12M | $-12M | $-31.0K | $843.0K | $-181.0K | $315.0K | |
| Debt Issued | · | · | · | · | · | $1M | · | · | · | · | · | |
| Stock Issued | $29M | $26M | $14M | $33M | $65M | $18M | $49M | $10M | · | $0 | $12M | |
| Net Stock Activity | $29M | $26M | $14M | · | · | · | · | · | · | $0 | · | |
| Financing Cash Flow | $28M | $20M | $12M | $36M | $78M | $23M | $48M | $12M | $10M | $10M | $12M | |
| Net Change in Cash | $3M | $-796.0K | $-12M | $-14M | $28M | $-15M | $16M | $434.0K | $-3M | $2M | $8M | |
| Taxes Paid | $0 | $0 | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-25M | $-21M | $-24M | · | · | · | · | · | · | $-8M | · |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 56.7% | 39.3% | 27.5% | · | · | · | · | · | · | · | · | |
| Operating Margin | -1260.8% | -3245.1% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| Net Margin | -1238.5% | -3225.0% | -1848.4% | · | · | · | · | · | · | 39885.7% | · | |
| Pretax Margin | · | -3225.0% | -1653.7% | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1206.6% | -3162.0% | -1672.4% | · | · | · | · | · | · | 39785.7% | · | |
| ROA | -165.1% | -110.3% | -31.8% | · | · | · | · | · | · | -82.2% | · | |
| ROE | 330.8% | 4733.8% | -98.2% | · | · | · | · | · | · | -110.1% | · | |
| ROIC | · | 497.3% | · | · | · | · | · | · | · | · | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.6 | 1.5 | · | · | · | · | · | · | 3.0 | · | |
| Quick Ratio | 1.1 | 1.4 | 1.4 | · | · | · | · | · | · | 2.4 | · |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | · | · | · | · | · | · | -0.0 | · | |
| Inventory Turnover | 4.1 | 5.1 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 3.0 | 1.8 | 2.8 | · | · | · | · | · | · | · | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 115.6% | 25.1% | 56.9% | -56.4% | 80.8% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 61.8% | -5.1% | 7.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 27.2% | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $2M | $2M | $958.0K | $2M | $1M | · | · | · | · | $0 | |
| Net Income TTM | $-50M | $-61M | $-28M | $-73M | $-64M | $-30M | $-22M | $-16M | $-19M | $-11M | $-9M | |
| Market Cap | $215M | $42M | $21M | · | · | · | · | · | · | $4.05B | · | |
| P/E | -4.5 | -0.5 | -0.7 | -0.5 | · | · | · | · | · | · | · | |
| P/S | 53.1 | 22.1 | 13.7 | · | · | · | · | · | · | · | · | |
| P/B | -6.8 | -3.4 | 1.0 | · | · | · | · | · | · | 410.9 | · | |
| P / Tangible Book | · | · | · | · | · | 355.7 | · | · | · | · | · | |
| P / Cash Flow | -9.7 | -2.0 | -0.9 | · | · | · | · | · | · | -538.7 | · | |
| P / FCF | -8.5 | -2.0 | -0.9 | · | · | · | · | · | · | -531.2 | · | |
| Earnings Yield | -22.0% | -195.8% | -150.0% | -206.4% | · | · | · | · | · | · | · |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $239.0K | $32.0K | $1M | $260.0K | $518.0K | $2M | $1M | $115.0K | $104.0K | $176.0K | $314.0K | $429.0K | $463.0K | $297.0K | $274.0K | $67.0K | |
| Cost of Revenue | $82.0K | $17.0K | $655.0K | $121.0K | $180.0K | $813.0K | $869.0K | $43.0K | $32.0K | $109.0K | $409.0K | $159.0K | $169.0K | $265.0K | $278.0K | $314.0K | |
| Gross Profit | $157.0K | $15.0K | $484.0K | $139.0K | $338.0K | $1M | $595.0K | $50.0K | $50.0K | $45.0K | $-117.0K | $248.0K | $272.0K | $10.0K | $-27.0K | $-269.0K | |
| R&D Expense | $4M | $5M | $6M | $4M | $3M | $3M | $2M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $1M | |
| SG&A Expense | $3M | $3M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | $2M | $4M | $3M | $5M | $6M | |
| Operating Expenses | $12M | $4M | $24M | $11M | $10M | $8M | $34M | $14M | $5M | $9M | $16M | $7M | $9M | $-6M | $12M | $1M | |
| Operating Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-14M | $-5M | $-9M | $-16M | $-7M | $-8M | $6M | $-12M | $-2M | |
| Other Non-op | $162.0K | $146.0K | $506.0K | $223.0K | $125.0K | $157.0K | $146.0K | $53.0K | $110.0K | $153.0K | $269.0K | $127.0K | $-1.0K | $-1.0K | $-365.0K | $62.0K | |
| Pretax Income | · | · | · | · | · | · | · | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $6M | $-12M | $-2M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-11M | $-4M | $-23M | $-11M | $-10M | $-7M | $-34M | $-13M | $-5M | $-9M | $-16M | $-6M | $-8M | $3M | $-45M | $-9M | |
| EPS (Basic) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| EPS (Diluted) | $-0.31 | $-0.12 | $-0.75 | $-0.34 | $-0.30 | $-0.26 | $-2.19 | $-0.98 | $-0.36 | $-1.13 | $-2.27 | $-0.81 | $-1.07 | $0.40 | $-10.04 | $-1.62 | |
| Shares (Basic) | 36,750,000 | 34,519,000 | -59,274,000 | 32,033,000 | 32,023,000 | 25,694,000 | -21,777,000 | 13,714,000 | 12,870,000 | 8,264,000 | -14,653,000 | 8,256,000 | 8,090,000 | 5,958,000 | -86,714,583 | 5,931 | |
| Shares (Diluted) | 36,750,000 | 34,519,000 | -59,274,000 | 32,033,000 | 32,023,000 | 25,694,000 | -21,777,000 | 13,714,000 | 12,870,000 | 8,264,000 | -14,658,000 | 8,256,000 | 8,090,000 | 5,963,000 | -86,714,583 | 5,931 | |
| EBITDA | $-11M | $-4M | · | $-10M | $-9M | $-6M | · | $-14M | $-5M | $-9M | · | $-7M | $-8M | $6M | · | $-9M |
대차대조표 21
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $28M | $12M | $19M | $24M | $31M | $9M | $3M | $9M | $6M | $9M | $14M | $17M | $12M | $20M | $32M | |
| Receivables | $192.0K | $157.0K | $1M | $258.0K | $512.0K | $4M | $2M | $209.0K | $85.0K | $161.0K | $484.0K | $2M | $2M | $2M | $2M | $2M | |
| Inventory | $207.0K | $382.0K | $446.0K | $471.0K | $693.0K | $459.0K | $410.0K | $232.0K | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $1M | $821.0K | $627.0K | $595.0K | $735.0K | $643.0K | $672.0K | $1M | $970.0K | $977.0K | $2M | |
| Current Assets | $21M | $31M | $15M | $21M | $27M | $36M | $12M | $5M | $10M | $7M | $11M | $17M | $21M | $16M | $26M | $37M | |
| PP&E (Net) | $6M | $9M | $9M | $6M | $6M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $7M | $8M | $9M | $9M | |
| Accum. Depreciation | $8M | $10M | $10M | $9M | $8M | $7M | $8M | $7M | $7M | $6M | $6M | $6M | $5M | $5M | $4M | $4M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $19M | |
| Intangibles | · | · | $0 | $15M | $15M | $15M | $15M | $57M | $57M | $57M | $57M | $57M | $57M | $57M | $62M | $88M | |
| Other Non-current Assets | $556.0K | $574.0K | $593.0K | $672.0K | $702.0K | $642.0K | $691.0K | $699.0K | $563.0K | $438.0K | $463.0K | $520.0K | $329.0K | $367.0K | $371.0K | $366.0K | |
| Total Assets | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Accounts Payable | $2M | $2M | $3M | $1M | $1M | $2M | $2M | $872.0K | $1M | $908.0K | $953.0K | $1M | $875.0K | $1M | $1M | $2M | |
| Accrued Liabilities | $2M | $3M | $2M | $2M | $1M | $3M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | $2M | $2M | $4M | |
| Current Liabilities | $10M | $12M | $12M | $8M | $7M | $10M | $7M | $9M | $7M | $8M | $7M | $8M | $8M | $9M | $12M | $13M | |
| Total Liabilities | $51M | $51M | $57M | $53M | $49M | $50M | $47M | $61M | $52M | $54M | $49M | $39M | $39M | $39M | $60M | $75M | |
| Common Stock | $395M | $394M | $369M | $369M | $368M | $367M | $338M | $327M | $326M | $311M | $310M | $310M | $310M | $296M | $295M | $293M | |
| Retained Earnings | $-416M | $-405M | $-401M | $-378M | $-367M | $-357M | $-351M | $-317M | $-304M | $-299M | $-290M | $-272M | $-266M | $-258M | $-261M | $-216M | |
| AOCI | $67.0K | $71.0K | $86.0K | $86.0K | $85.0K | $41.0K | $21.0K | $57.0K | $37.0K | $40.0K | $49.0K | $32.0K | $41.0K | $43.0K | $39.0K | $19.0K | |
| Stockholders' Equity | $-21M | $-11M | $-31M | $-9M | $1M | $10M | $-12M | $10M | $23M | $12M | $20M | $38M | $44M | $38M | $34M | $77M | |
| Liabilities + Equity | $29M | $40M | $26M | $44M | $51M | $60M | $35M | $70M | $75M | $71M | $75M | $82M | $88M | $83M | $100M | $157M | |
| Shares Outstanding | 32,623,000 | 32,286,000 | 28,683,000 | 28,625,000 | 28,617,000 | 28,599,000 | 17,453,000 | 13,374,000 | 13,368,000 | 8,273,000 | 8,261,000 | 8,261,000 | 8,241,000 | 119,279,000 | 5,932,000 | 118,619,000 |
현금 흐름 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $665.0K | $631.0K | $563.0K | $584.0K | $559.0K | $491.0K | $563.0K | $340.0K | $326.0K | $335.0K | $303.0K | $404.0K | $435.0K | $450.0K | $466.0K | $391.0K | |
| Stock-based Comp | $661.0K | $615.0K | $721.0K | $521.0K | $504.0K | $473.0K | $499.0K | $450.0K | $386.0K | $418.0K | $484.0K | $608.0K | $834.0K | $834.0K | $3M | $3M | |
| Amort. of Intangibles | $0 | $0 | $0 | $0 | $0 | $7.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $22.0K | $812.0K | $976.0K | |
| Other Non-cash | · | $-5M | · | · | · | $-151.0K | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-6M | $-5M | $-6M | $-6M | $-5M | $-6M | $-6M | $-4M | $-4M | $-2M | $-5M | $-8M | $-10M | $-11M | |
| CapEx | $779.0K | $613.0K | $1M | $1M | $349.0K | $307.0K | $214.0K | $87.0K | $191.0K | $24.0K | $264.0K | · | · | · | $802.0K | $859.0K | |
| Investing Cash Flow | $-779.0K | $-613.0K | $-1M | $-1M | $-349.0K | $-307.0K | $-210.0K | $-87.0K | $-191.0K | $-24.0K | $103.0K | $-1M | $123.0K | $-1M | $-802.0K | $-859.0K | |
| Stock Issued | $0 | $26M | $0 | $0 | $0 | $29M | $10M | $0 | $16M | $0 | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | $26M | · | · | · | $29M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-564.0K | $25M | $-252.0K | $-120.0K | $-114.0K | $29M | $11M | $-255.0K | $10M | $0 | $-30.0K | $-30.0K | $12M | $-28.0K | $-100.0K | $-572.0K | |
| Net Change in Cash | $-11M | $16M | $-7M | $-6M | $-7M | $22M | $5M | $-6M | $4M | $-4M | $-4M | $-4M | $6M | $-10M | $-11M | $-13M | |
| Taxes Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | · | |
| Free Cash Flow | · | $-8M | · | · | · | $-6M | · | · | · | $-4M | · | · | · | · | · | · |
수익성 7
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.7% | 46.9% | · | 53.5% | 67.6% | 62.0% | · | 43.5% | 48.1% | -55.7% | · | 57.8% | 58.8% | 3.4% | · | -115.4% | |
| Operating Margin | -4770.7% | -13790.6% | · | -4249.2% | -1900.0% | -318.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| Net Margin | -4711.3% | -13406.2% | · | -4174.6% | -1880.7% | -312.0% | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 1021.2% | · | -917.7% | |
| Pretax Margin | · | · | · | · | · | · | · | -11733.0% | -4355.8% | -5186.9% | · | -1512.6% | -1799.8% | 2006.4% | · | -917.7% | |
| EBITDA Margin | -4492.5% | -11818.8% | · | -4024.6% | -1792.1% | -295.0% | · | -11752.2% | -4453.9% | -5265.3% | · | -1518.2% | -1791.4% | 1952.2% | · | -906.7% | |
| ROA | -28.2% | -8.5% | · | -19.0% | -15.6% | -10.2% | · | -17.8% | -5.6% | -11.9% | · | -5.4% | -6.4% | 2.6% | · | -5.7% | |
| ROE | 111.5% | 1814.0% | · | -4215.1% | -81.9% | -61.2% | · | -57.1% | -13.7% | -36.9% | · | -11.3% | -13.1% | 6.4% | · | -10.6% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 2.5 | · | 2.8 | 4.0 | 3.7 | · | 0.5 | 1.4 | 0.8 | · | 2.1 | 2.7 | 1.7 | · | 2.8 | |
| Quick Ratio | 1.7 | 2.4 | · | 2.5 | 3.7 | 3.6 | · | 0.4 | 1.3 | 0.7 | · | 2.0 | 2.5 | 1.5 | · | 2.6 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.2 | 0.0 | · | 0.3 | 0.5 | 3.5 | · | 0.4 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 0.7 | 0.0 | · | 1.1 | 1.7 | 1.2 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.3 | 0.1 | · | 0.7 |
가치 평가 (TTM) 9
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $3M | · | $3M | $3M | $3M | · | $824.0K | $1M | $1M | · | $1M | $1M | $981.0K | · | $4M | |
| Net Income TTM | $-36M | $-32M | · | $-41M | $-34M | $-34M | · | $-34M | $-28M | $-21M | · | $-21M | $-23M | $-25M | · | $-64M | |
| Market Cap | $192M | $106M | · | $95M | $86M | $88M | · | $38M | $39M | $24M | · | $26M | $38M | $844M | · | $1.73B | |
| P/E | -5.5 | -3.2 | · | -1.8 | -1.6 | -1.1 | · | -0.9 | -0.9 | -1.1 | · | -1.0 | -1.2 | -2.5 | · | · | |
| P/S | 183.5 | 35.9 | · | 31.4 | 30.1 | 34.5 | · | 46.3 | 33.6 | 17.8 | · | 20.5 | 35.6 | 860.9 | · | 405.3 | |
| P/B | -9.0 | -9.9 | · | -10.3 | 78.7 | 8.6 | · | 3.9 | 1.7 | 2.1 | · | 0.7 | 0.9 | 22.3 | · | 22.5 | |
| P / Cash Flow | · | -13.9 | · | · | · | -14.9 | · | · | · | -6.3 | · | · | · | -87.3 | · | · | |
| P / FCF | · | -12.8 | · | · | · | -14.2 | · | · | · | -6.3 | · | · | · | · | · | · | |
| Earnings Yield | -18.1% | -31.1% | · | -56.6% | -62.9% | -89.2% | · | -115.1% | -114.2% | -89.1% | · | -99.4% | -82.0% | -39.7% | · | · |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $4M | $2M | $2M | $958.0K | $2M |
| 매출 총이익률 % | 56.7% | 39.3% | 27.5% | — | — |
| 영업이익률 % | -1260.8% | -3245.1% | -1672.4% | — | — |
| 순이익 | $-50M | $-61M | $-28M | $-73M | $-64M |
| 희석 EPS | $-1.65 | $-4.66 | $-3.75 | $-13.25 | — |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 1.3 | 1.6 | 1.5 | — | — |
| 당좌 비율 | 1.1 | 1.4 | 1.4 | — | — |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-25M | $-21M | $-24M | — | — |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 43개의 제출자 · $106.4M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 11 (-6 이전 분기 대비) | 13 (+6 이전 분기 대비) | 9 (0 이전 분기 대비) | 8 (+1 이전 분기 대비) | -519K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
회사 내부자 29 명의 내부자 · 16 임원 · 13 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Josh Riggs | CEO and President | 2026년 3월 26일 M | 38,365 | 0 | 0 | $0 |
| Ronald Asbury Andrews | Former CEO | 2022년 12월 7일 A | 583,212 | 0 | 0 | $0 |
| William Annett | President and CEO | 2019년 3월 14일 A | 3,500 | 0 | 0 | $0 |
| Andrea S. James | Chief Financial Officer | 2026년 3월 26일 M | 206,060 | 0 | 0 | $0 |
| Anish M. John | Chief Financial Officer | 2023년 2월 24일 A | 150,000 | 0 | 0 | $0 |
| Mitchell S Levine | Chief Financial Officer | 2022년 3월 15일 A | 87,080 | 0 | 0 | $0 |
| Gisela Paulsen | Former President and COO | 2022년 12월 16일 D | 366,500 | 0 | 0 | $0 |
| Albert P Parker | COO | 2020년 12월 11일 A | 10,586 | 0 | 0 | $0 |
| James Yang Liu | VP ACCT, Cntlr, Treasurer, PAO | 2026년 3월 26일 M | 3,711 | 0 | 0 | $0 |
| Douglas T. Ross | Former CSO | 2022년 12월 21일 A | 234,114 | 0 | 0 | $0 |
| Li Yu | VP Cntrllr/Prncpl Acctng Offcr | 2022년 5월 18일 M | 16,872 | 0 | 0 | $0 |
| Padma Sundar | Chief Commercial Officer | 2022년 3월 15일 A | 4,177 | 0 | 0 | $0 |
| Lyndal K. Hesterberg | CSO | 2020년 12월 11일 A | 7,477 | 0 | 0 | $0 |
| Tony T Kalajian | Sr.VP/Chief Accounting Officer | 2020년 8월 3일 P | 15,000 | 0 | 0 | $0 |
| Kristine C. Mechem | VP of Marketing | 2018년 6월 7일 A | — | 0 | 0 | $0 |
| Karen B. Chapman | Vice President of Research | 2016년 2월 16일 A | — | 0 | 0 | $0 |
| Andrew J. Last | 이사 | 2026년 7월 1일 F | 58,752 | 0 | 0 | $0 |
| Andrew Arno | 이사 | 2026년 7월 1일 F | 156,785 | 0 | 0 | $0 |
| Lou Silverman | 이사 | 2026년 7월 1일 F | 55,807 | 0 | 0 | $0 |
| Alfred D Kingsley | 이사 | 2023년 6월 23일 A | 489,111 | 0 | 0 | $0 |
| Jennifer L. Carter | 이사 | 2022년 8월 15일 A | 30,500 | 0 | 0 | $0 |
| Melinda Griffith | 이사 | 2022년 8월 15일 A | 30,000 | 0 | 0 | $0 |
| Cavan M. Redmond | 이사 | 2022년 6월 24일 M | 120,863 | 0 | 0 | $0 |
| Aditya P. Mohanty | 이사 | 2019년 7월 17일 A | — | 0 | 0 | $0 |
| Don M Bailey | 이사 | 2017년 6월 15일 A | — | 0 | 0 | $0 |
| Michael D West | 이사 | 2016년 2월 16일 A | — | 0 | 0 | $0 |
| Patrick W Smith | 10% 소유주 | 2025년 2월 7일 J | 3,258,485 | 0 | 0 | $0 |
| John Peter Gutfreund | — | 2023년 6월 30일 J | 0 | 0 | 0 | $0 |
| BIOTIME INC | — | 2020년 1월 2일 S | 6,041,154 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 5 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Broadwood Partners, L.P., Broadwood Capital, Inc., Neal C. Bradsher ×15 제출 서류 | 2026년 4월 27일 | 39.70% | 수정본 | 수동적 투자 | SEC |
| Lineage Cell Therapeutics, Inc. 1 S.S. OR ×4 제출 서류 | 2021년 1월 8일 | — | 최초 제출 | — | SEC |
| BioTime, Inc. 1 S.S. OR ×5 제출 서류 | 2019년 7월 5일 | — | 최초 제출 | — | SEC |
| BioTime, Inc. S.S. OR | 2016년 8월 29일 | — | 최초 제출 | 이사회 캠페인 | SEC |
| BioTime, Inc. | 2015년 12월 31일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 3 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.